Classifying your IVD PowerPoint PPT Presentation

Risk Associated with IVDs. Risks of IVD to patients and users can range from little or no risks to patients and users significant potential riskHence the level of regulation should be proportional to the level of potential risk, taking account of the benefits offered by the deviceRisk based clas

Copyright Complaint Adult Content Flag as Inappropriate

Download Presentation

Classifying your IVD

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

Presentation Transcript

2. Risk Associated with IVDs Risks of IVD to patients and users can range from
little or no risks to patients and users
significant potential risk
Hence the level of regulation should be proportional to the level of potential risk, taking account of the benefits offered by the device
Risk based classification system based on GHTF guidelines

3. How Potential Risk is Determined the intended use and indications as specified by the manufacturer
Specific disorder, condition or risk factor for which the test is intended
The technical/ scientific/ medical expertise of the intended user
eg lab testing vs home use

4. How Potential Risk is Determined The importance of the information to the diagnosis
Sole determinant or one of several
The impact of the result (true or false) to the individual and/or to public health

5. How Potential Risk is Determined
These guidelines are encompassed in a set of classification rules
Rules classify all IVD into 4 different classes
The rules are capable of accommodating future technological developments
These mirror GHTF rules

6. Why Classify?
The purpose of classification rules is to determine the level of regulatory oversight required
The class of device determines the conformity assessment procedure

9. Class 2 Devices in this class represent a low public health risk, and moderate personal risk
Includes those IVD that
detect the presence or exposure to infectious agents not easily propagated in Aust and NZ
Cause self-limiting disease
Not used exclusively in a diagnostic setting
An erroneous result rarely puts the individual in immediate danger

11. Class 3 Devices in this class represent a moderate public health risk, and high individual risk
Includes those IVD that
detect the presence or exposure to infectious agents that are easily propagated in Aust and NZ
An erroneous result may have a major negative impact on outcome
Where the IVD provides the critical or sole determinant for a correct diagnosis

13. Class 3 moderate public health risk, high individual risk
Includes
Detecting the presence of, or exposure to, a serious sexually transmitted agent. Such as Chlamydia trachomatis, Neisseria gonorrhoeae etc.
Detecting the presence in cerebrospinal fluid or blood of an infectious agent that constitutes a significant public health risk. Examples: Neisseria meningitidis or Cryptococcus neoformans.
Determining infective disease status or immune status, and where there is a risk that an erroneous result will lead to a patient management decision resulting in an imminent life-threatening situation for the patient. Example: Influenza, Haemophilus influenzae B

14. Class 3 moderate public health risk, high individual risk
Includes
Detecting the presence of an infectious agent where there is a significant risk that an erroneous result would cause death or severe disability to the individual or foetus being tested. Examples: Toxoplasma, Varicella Zoster Virus.
Screening pre-natal women in order to determine their immune status towards transmissible agents. Examples: Rubella.

15. Class 3 moderate public health risk, high individual risk
Includes
Screening for, or in the diagnosis of, cancer, including cancer staging, where initial therapeutic decisions will be made based on the outcome of the test results.
Predictive genetic screening, when the outcome of the test would ordinarily result in a substantial impact on the life of the individual. Examples: Guthrie test for phenylketonuria, Huntington’s Disease, Cystic Fibrosis.

16. Class 3 moderate public health risk, high individual risk
Includes
Monitoring levels of medicines, substances or biological components, when there is a risk that an erroneous result will lead to a patient management decision resulting in an immediate life-threatening situation for the patient.
Examples: Cardiac markers, cyclosporine, prothrombin time testing, digoxin, paracetamol, Gentamycin, Tobramycin, potassium, calcium, troponin, glucose, taerolimus, serolimus

17. Class 4 Devices in this class represent a high public health risk, and high individual risk
Includes all IVDs used for universal screening of the blood supply and organ and tissue donations for pathogens
HIV, HCV, HBV, Syphilis, HTLV
Includes IVDs for these agents used in a diagnostic role
IVDs for these agents intended only for monitoring are captured under a separate role - are Class III

18. Class 4 high public health risk, high individual risk
Includes IVDs with an intended function of detecting agents used in biowarfare
eg anthrax
Includes high risk blood grouping tests
ABO, rhesus, anti-Kell

19. Points to remember The manufacturer is responsible for applying the classification rules
The classification rules are based on the manufacturer’s intended purposes and in some cases, more than 1 rule may apply
If this happens the higher classification applies

20. Points to remember The classification must be consistent with the information accompanying the IVD
including the label, directions for use, brochures and operating manuals
If the intended purpose is not clear, the Joint Agency will assign an intended purpose
consistent with purpose generally accepted in clinical practice

21. Points to remember Calibrators and control materials intended to be used with an IVD reagent should be treated in the same class as the IVD itself
Software intended to drive or influence the use of the IVD falls under the same classification as the IVD